Propionic Acid

Propionic Acid

SCHEMBL4160167

CC(C)(C)OC(=O)Nc1ccccc1-c1ccc2[nH]c(=O)c3[nH]ccc3c2c1.CCC(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.42
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRA6 Q16445 1/20 0.39
PARP14 Q460N5 4/20 0.38
CNR2 P34972 1/20 0.36
METAP2 P50579 1/20 0.35
HDAC1 Q13547 1/20 0.35
BRD9 Q9H8M2 1/20 0.34
TLR9 Q9NR96 1/20 0.34
TLR8 Q9NR97 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
CHRM3 P20309 1/20 0.34
SCN9A Q15858 2/20 0.34
RXFP1 Q9HBX9 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4166411 0.86 MAP4K4 (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
Propionic Acid SCHEMBL4155395 0.85 CYP17A1 (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
Propionic Acid SCHEMBL4157496 0.82 MCL1 (0.45) TRPV1PARP14METAP2
Propionic Acid SCHEMBL4155354 0.80 PAK1 (0.50)
SCHEMBL4160163 0.80 TRPV1 (0.41) TRPV1GABRA1GABRG2GABRB3GABRA5
SCHEMBL3254005 0.80 TRPV1 (0.43) TRPV1GABRA1GABRG2GABRB3GABRA5
Propionic Acid SCHEMBL4153840 0.80 PIM1 (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
Propionic Acid SCHEMBL4165833 0.79 PAK1 (0.40) METAP2BRD4PIM1
SCHEMBL4713726 0.79 CYP17A1 (0.48) GABRA1GABRG2GABRB3GABRA5GABRA3
Propionic Acid SCHEMBL4163246 0.78 PPARG (0.41) PARP14PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 TRPV1 2417/4885GABRA1 3395/4885GABRG2 2327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.